Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole PK in CYP2C19 Poor Metabolizers
NCT02906176Phase 1Completed
- Sponsor
- Seoul National University Hospital
- Start
- Sep 2016
- Primary completion
- Nov 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of voriconazole in fungal infection (2 arms), sponsored by Seoul National University Hospital. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve. Started Sep 2016; status: completed.
02
Drugs
voriconazole
03
Conditions
fungal infection
Beyond the preview
Go deeper on NCT02906176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02906176.